Nordic Nanovector ASA: Invitation to First Quarter 2017 Results Presentation and Webcast
Oslo, Norway, 16 May 2017 Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics for haematological cancers, will announce its first quarter 2017 results on Wednesday, 24th of May 2017. A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CET at:Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 OsloMeeting Room: NYLAND The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investor Relations/Webcast.